New Trial on Cancer-Related Anxiety Drug Psilocybin
A new trial shows psychotropic drug psilocybin has helped reduce anxiety in cancer patients in conjunction with psychotherapy.
Category: clinical trials
New Mesothelioma Biomarker Shows Promise
A new biomarker (FGF18) has shown promise for patients with pleural mesothelioma according to a paper presented at the World Conference on Lung Canter.
New Breath Test Could Detect Mesothelioma Earlier Than Other Diagnostic Methods
Medical researchers in Belgium have found a new way to detect mesothelioma early by analyzing the breath signatures of individuals exposed to asbestos.
New Mesothelioma Immunotherapy Clinical Trial at Baylor University
A new clinical trial at Baylor University’s Mesothelioma Treatment Center is looking at the effectiveness of using immunotherapy before surgery.
Immunotherapy Could Change the Way Mesothelioma and Other Cancers Are Treated
Immunotherapy could change the way many cancers, including mesothelioma, are treated.
Immunotherapy Could Change the Way Mesothelioma and Other Cancers Are Treated
Immunotherapy could change the way many cancers, including mesothelioma, are treated.
UK Doctors Question Benefits of EPP Surgery for Mesothelioma Patients
A group of doctors in the United Kingdom is questioning the continuation of EPP surgery for mesothelioma patients.
Potential Mesothelioma Drug Wins Orphan Status from the European Commission
Cambridge, Mass.-based Verastem hopes to bring to the table a new treatment option for patients with asbestos-caused cancer
Angeles Clinic and Research Institute Opens Mesothelioma-Specific Clinical Trial
A new Phase 2 clinical trial at the Angeles Clinic will study tremelimumab as an immunotherapy treatment for pleural and peritoneal mesothelioma.
New Immunotherapy Drug Works with Lung Cancer, Might Be Future for Mesothelioma Treatment
An Immunotherapy drug testing well with lung cancer has become a future hope for mesothelioma treatment.